Fibrodysplasia Ossificans Progressiva
Angelica R. Putnam, MD
Key Facts
Terminology
Rare disabling genetic disorder of progressive heterotopic ossification
Etiology/Pathogenesis
Heterozygous activating mutation of gene encoding activin receptor A type 1/activin-like kinase 2 (ACVR1/ALK2)
Clinical Issues
Approximately 1 in 2, 000, 000 persons
Childhood onset
No treatment exists
Microscopic Pathology
Early lesions are nodular fasciitis-like
Progressive ossification similar to that of myositis ossificans
TERMINOLOGY
Abbreviations
Fibrodysplasia ossificans progressiva (FOP, FDOP)
Synonyms
Myositis ossificans progressiva, stone man disease
Definitions
Rare disabling genetic disorder of progressive heterotopic ossification
ETIOLOGY/PATHOGENESIS
Genetics
Heterozygous activating mutation of gene encoding activin receptor A type 1/activin-like kinase 2 (ACVR1/ALK2)Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree